相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BRCA1/P53: Two strengths in cancer chemoprevention
Liliana Raimundo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
p53, cancer and the immune response
Julianne Blagih et al.
JOURNAL OF CELL SCIENCE (2020)
Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
Khaphetsi Joseph Mahasa et al.
SCIENTIFIC REPORTS (2020)
Human chimeric antigen receptor macrophages for cancer immunotherapy
Michael Klichinsky et al.
NATURE BIOTECHNOLOGY (2020)
Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma
A-Rum Yoon et al.
CANCER RESEARCH (2019)
Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
Julia Niemann et al.
NATURE COMMUNICATIONS (2019)
A tumor targeting oncolytic adenovirus can improve therapeutic outcomes in chemotherapy resistant metastatic human breast carcinoma
Ali Sakhawat et al.
SCIENTIFIC REPORTS (2019)
State-of-the-art human adenovirus vectorology for therapeutic approaches
Jian Gao et al.
FEBS LETTERS (2019)
Viral Vector-Based Delivery of CRISPR/Cas9 and Donor DNA for Homology-Directed Repair in an In Vitro Model for Canine Hemophilia B
Jian Gao et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)
Manuel Piechutta et al.
ESMO OPEN (2019)
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non muscle-invasive bladder cancer: Interim results
Vignesh T. Packiam et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
Vincenzo Cerullo et al.
CURRENT CANCER DRUG TARGETS (2018)
The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
Wei-Wei Zhang et al.
HUMAN GENE THERAPY (2018)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment
M. Garofalo et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors
Peter Abbink et al.
JOURNAL OF VIROLOGY (2018)
Seamless assembly of recombinant adenoviral genomes from high-copy plasmids
Jessica J. Miciak et al.
PLOS ONE (2018)
Novel Vector Construction Based on Alternative Adenovirus Types via Homologous Recombination
Wenli Zhang et al.
HUMAN GENE THERAPY METHODS (2018)
Designer Oncolytic Adenovirus: Coming of Age
Alexander T. Baker et al.
CANCERS (2018)
First-in-child trial of celyvir (autologous mesenchymal stem cells carrying the oncolytic virus ICOVIR-5) in patients with relapsed and refractory pediatric solid tumors.
Manuel Ramirez et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy
Sadia Zafar et al.
ONCOIMMUNOLOGY (2018)
Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies
Mariangela Garofalo et al.
VIRUSES-BASEL (2018)
The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model
Xiaozhu Li et al.
CLINICAL CANCER RESEARCH (2017)
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
E. Eriksson et al.
GENE THERAPY (2017)
Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer
Di Yu et al.
NEUROENDOCRINOLOGY (2017)
De-novo and acquired resistance to immune checkpoint targeting
Nicholas L. Syn et al.
LANCET ONCOLOGY (2017)
An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity
Wenli Zhang et al.
CELL REPORTS (2017)
Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition
Sakhawat Ali et al.
JOURNAL OF CANCER (2017)
Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
Rocio Garcia-Carbonero et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Combining Oncolytic Adenovirus with Radiation-A Paradigm for the Future of Radiosensitization
Sean M. O'Cathail et al.
FRONTIERS IN ONCOLOGY (2017)
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer
Stephano S. Mello et al.
CANCER CELL (2017)
Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
Emma Eriksson et al.
CLINICAL CANCER RESEARCH (2017)
Oncolytic virus DNX-2401 with a short course of temozolomide for glioblastoma at first recurrence: Clinical data and prognostic biomarkers
Marta M. Alonso et al.
CANCER RESEARCH (2017)
Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
Daniel H. Sterman et al.
CLINICAL CANCER RESEARCH (2016)
Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer
Ilkka Liikanen et al.
MOLECULAR CANCER THERAPEUTICS (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Phase I study with ONCOS-102 for the treatment of solid tumors - an evaluation of clinical response and exploratory analyses of immune markers
Tuuli Ranki et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Two distinct effector memory cell populations of WT1 (Wilms' tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients
Yoshiki Nakae et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study
Peter Johnson et al.
CLINICAL CANCER RESEARCH (2015)
Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA
Yang Gao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21
Xiaomei Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Human mastadenovirus type 70: a novel, multiple recombinant species D mastadenovirus isolated from diarrhoeal faeces of a haematopoietic stem cell transplantation recipient
Elias Hage et al.
JOURNAL OF GENERAL VIROLOGY (2015)
CD8+ CD103+ Tumor-Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
Faycal Djenidi et al.
JOURNAL OF IMMUNOLOGY (2015)
Human Adenovirus 52 Uses Sialic Acid-containing Glycoproteins and the Coxsackie and Adenovirus Receptor for Binding to Target Cells
Annasara Lenman et al.
PLOS PATHOGENS (2015)
The Human Agonistic CD40 Antibody ADC-1013 Eradicates Bladder Tumors and Generates T-cell-Dependent Tumor Immunity
Sara M. Mangsbo et al.
CLINICAL CANCER RESEARCH (2015)
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma
Mikko Siurala et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
V. A. Jennings et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
Svend O. Freytag et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Unravelling mechanisms of p53-mediated tumour suppression
Kathryn T. Bieging et al.
NATURE REVIEWS CANCER (2014)
Immune cells: more than simple carriers for systemic delivery of oncolytic viruses
Samuel Eisenstein et al.
ONCOLYTIC VIROTHERAPY (2014)
Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation
Munitta Muthana et al.
CANCER RESEARCH (2013)
Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy
Samuel Eisenstein et al.
CANCER RESEARCH (2013)
Treatment of patients with advanced cancer with the natural killer cell line NK-92
Torsten Tonn et al.
CYTOTHERAPY (2013)
Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells
Robert A. Adair et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
A Preclinical Evaluation of Neural Stem CellBased Cell Carrier for Targeted Antiglioma Oncolytic Virotherapy
Atique U. Ahmed et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects
Padma Sampath et al.
MOLECULAR THERAPY (2013)
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement
Zhili Xu et al.
NATURE MEDICINE (2013)
Molecular evolution of human adenoviruses
Christopher M. Robinson et al.
SCIENTIFIC REPORTS (2013)
The Timing of Neural Stem Cell-Based Virotherapy Is Critical for Optimal Therapeutic Efficacy When Applied With Radiation and Chemotherapy for the Treatment of Glioblastoma
Alex L. Tobias et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
Myeloid-derived suppressor cells as a Trojan horse A cellular vehicle for the delivery of oncolytic viruses
Ping-Ying Pan et al.
ONCOIMMUNOLOGY (2013)
Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
K. Oberg et al.
ANNALS OF ONCOLOGY (2012)
Human Telomerase Reverse Transcriptase (hTERT) Is a Novel Target of the Wnt/β-Catenin Pathway in Human Cancer
Yong Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes following Vaccination of Rhesus Monkeys
Hualin Li et al.
JOURNAL OF VIROLOGY (2012)
Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer
Otto Hemminki et al.
MOLECULAR THERAPY (2012)
Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting
Jun Fu et al.
NATURE BIOTECHNOLOGY (2012)
Adenovirus receptors: implications for targeting of viral vectors
Niklas Arnberg
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Oncolytic adenovirus based on serotype 3
O. Hemminki et al.
CANCER GENE THERAPY (2011)
Mining the adenovirus virome for oncolytics against multiple solid tumor types
C. Y. Chen et al.
CANCER GENE THERAPY (2011)
Species D Adenoviruses as Oncolytics against B-cell Cancers
Christopher Y. Chen et al.
CLINICAL CANCER RESEARCH (2011)
Serotype-Specific Inactivation of the Cellular DNA Damage Response during Adenovirus Infection
Natalie A. Forrester et al.
JOURNAL OF VIROLOGY (2011)
Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
Di Yu et al.
JOURNAL OF VIROLOGY (2011)
A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant Glioma
Atique U. Ahmed et al.
MOLECULAR PHARMACEUTICS (2011)
Neural Stem Cell-based Cell Carriers Enhance Therapeutic Efficacy of an Oncolytic Adenovirus in an Orthotopic Mouse Model of Human Glioblastoma
Atique U. Ahmed et al.
MOLECULAR THERAPY (2011)
Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
Hongjie Wang et al.
NATURE MEDICINE (2011)
The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis
Emma C. Nilsson et al.
NATURE MEDICINE (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
Jens Rueter et al.
CANCER BIOLOGY & THERAPY (2010)
A Novel Oncolytic Adenovirus Expressing Escherichia coli Cytosine Deaminase Exhibits Potent Antitumor Effect on Human Solid Tumors
Jufeng Zhang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients
Vincenzo Cerullo et al.
CANCER RESEARCH (2010)
Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses
Juan J. Rojas et al.
MOLECULAR THERAPY (2010)
Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
Anniina Koski et al.
MOLECULAR THERAPY (2010)
Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability
Justyna Leja et al.
PLOS ONE (2010)
Looking Inside Adenovirus
Stephen C. Harrison
SCIENCE (2010)
Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer-Preclinical Background: CTLA-4 and PD-1 Blockade
Jeffrey Weber
SEMINARS IN ONCOLOGY (2010)
Targeting p53 for enhanced radio- and chemo-sensitivity
Chao Lu et al.
APOPTOSIS (2009)
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
Robert C. Carlisle et al.
BLOOD (2009)
Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo
I. V. Ulasov et al.
BRITISH JOURNAL OF CANCER (2009)
Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
E. J. Ilett et al.
GENE THERAPY (2009)
Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma
Ranjana Advani et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Temporal Regulation of the Mre11-Rad50-Nbs1 Complex during Adenovirus Infection
Kasey A. Karen et al.
JOURNAL OF VIROLOGY (2009)
Enzymatic assembly of DNA molecules up to several hundred kilobases
Daniel G. Gibson et al.
NATURE METHODS (2009)
The Janus faces of CD40 in cancer
Angelica S. I. Loskog et al.
SEMINARS IN IMMUNOLOGY (2009)
Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells
Suvobroto Nandi et al.
CANCER RESEARCH (2008)
Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
S. Arai et al.
CYTOTHERAPY (2008)
Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery
S. H. Thorne et al.
GENE THERAPY (2008)
The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer
David H. Lynch
IMMUNOLOGICAL REVIEWS (2008)
Evaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanoma
Dennis Hoffmann et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
Irene Kuhn et al.
PLOS ONE (2008)
Virus-mediated oncolysis induces danger signal and stimulates cytotoxic T-lymphocyte activity via proteasome activator upregulation
Y. Endo et al.
ONCOGENE (2008)
Improved gtioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses
Dennis Hoffmann et al.
JOURNAL OF GENE MEDICINE (2007)
Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer
Svend O. Freytag et al.
MOLECULAR THERAPY (2007)
Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma
Ilya V. Ulasov et al.
HUMAN GENE THERAPY (2007)
A novel chromogranin-A promoter-driven oncolytic adenovirus for midgut carcinoid therapy
Justyna Leja et al.
CLINICAL CANCER RESEARCH (2007)
Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance
Maha Othman et al.
BLOOD (2007)
Evaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcoma
Dennis Hoffmann et al.
HUMAN GENE THERAPY (2007)
Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer
Luni Emdad et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy
PD Boucher et al.
CANCER RESEARCH (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
JA Bonner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity
KN Barton et al.
MOLECULAR THERAPY (2006)
CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7
M Marttila et al.
JOURNAL OF VIROLOGY (2005)
Chimeric Ad5 vectors expressing the short fiber of Ad41 show reduced affinity for human intestinal epithelium
Filippos Kesisoglou et al.
MOLECULAR PHARMACEUTICS (2005)
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells
C Cole et al.
NATURE MEDICINE (2005)
Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity
J Dilley et al.
CANCER GENE THERAPY (2005)
The adenovirus E4orf6 protein inhibits DNA double strand break repair and radiosensitizes human tumor cells in an E1B-55K-independent manner
LS Hart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Current status of gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers
ZH Peng
HUMAN GENE THERAPY (2005)
Novel replication-incompetent vector derived from adenovirus type 11 (Ad11) for vaccination and gene therapy: Low seroprevalence and non-cross-reactivity with Ad5
L Holterman et al.
JOURNAL OF VIROLOGY (2004)
Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model
V Tsai et al.
CLINICAL CANCER RESEARCH (2004)
Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells
M Nilsson et al.
JOURNAL OF GENE MEDICINE (2004)
Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells
AM Leen et al.
BLOOD (2004)
Enhanced adenovirus infection of melanoma cells by fiber-modification - Incorporation of RGD peptide or Ad5/3 chimerism
AL Volk et al.
CANCER BIOLOGY & THERAPY (2003)
Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors
Z Fishelson et al.
MOLECULAR IMMUNOLOGY (2003)
Potentiation of radiation therapy by the oncolytic adenovirus dl 1520 (ONYX-015) in human malignant glioma xenografts
B Geoerger et al.
BRITISH JOURNAL OF CANCER (2003)
Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein
K Toth et al.
CANCER GENE THERAPY (2003)
Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber
T Nakamura et al.
JOURNAL OF VIROLOGY (2003)
CD46 is a cellular receptor for group B adenoviruses
A Gaggar et al.
NATURE MEDICINE (2003)
4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function
T Wen et al.
JOURNAL OF IMMUNOLOGY (2002)
Targeted adenoviral vectors
BG Barnett et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease
MJE Havenga et al.
JOURNAL OF VIROLOGY (2002)
4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy
JL Cannons et al.
JOURNAL OF IMMUNOLOGY (2001)
Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region
LK Hawkins et al.
GENE THERAPY (2001)
Phase I study of recombinant human CD40 ligand in cancer patients
RH Vonderheide et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy
A Rahman et al.
MOLECULAR THERAPY (2001)
The Rb/E2F pathway and cancer
JR Nevins
HUMAN MOLECULAR GENETICS (2001)
Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial
S Mulvihlll et al.
GENE THERAPY (2001)
Adenovirus-mediated wild-type p53 gene expression radiosensitizes non-small cell lung cancer cells but not normal lung fibroblasts
S Kawabe et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2001)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
分享论文
